NPS Pharmaceuticals to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference

BEDMINSTER, N.J., Feb. 29 NPS Pharmaceuticals,Inc. (Nasdaq: NPSP) announced today that Francois Nader, M.D., executive vicepresident, chief operating officer, and chief executive officer-elect isscheduled to present at the Lehman Brothers Eleventh Annual Global HealthcareConference in Miami on Wednesday, March 19, 2008 at 3:15 p.m. ET. Thepresentation will be available as a live webcast with a replay availableapproximately 24 hours after the presentation has concluded. Interestedparties may access the webcast from the NPS website, http://www.npsp.com.

About NPS Pharmaceuticals

NPS Pharmaceuticals is developing high value specialty therapeutics forgastrointestinal and endocrine disorders. The company is currently advancingtwo late-stage programs: GATTEX(TM) (teduglutide) is in Phase 3 clinicaldevelopment for intestinal failure associated with short bowel syndrome andparathyroid hormone 1-84 [rDNA origin] injection is in Phase 2 clinicaldevelopment as a hormone therapy for hypoparathyroidism. NPS has alsocompleted a Phase 3 osteoporosis study for PREOS(R) (parathyroid hormone 1-84[rDNA origin] injection). NPS complements its internal programs withstrategic partnerships, which include Amgen, GlaxoSmithKline, Kirin, andNycomed. Additional information is available at http://www.npsp.com.

SOURCE NPS Pharmaceuticals, Inc.

Latest Press Release on General News

Philips Shareholders Approve all Proposals at the AGM 2024

May 7, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that its shareholders approved all proposals at the Annual General Meeting of Shar...

Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division

VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Today marks a pivotal development for Brains Bioceutical Corp ("Brains Bio"), as it significantly strengthens its Veterin...

Nicklaus Children's Health System, Philips to Provide Innovative Patient and Staff Experience, Helping to Enhance Outcomes for the Smallest of Patients

April 30, 2024 Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic c...

Cinesteam® Is a Deodorizing Support Tool for Palliative Care

Palliative Care Is a Comprehensive Approach to Long-Term Patient Care. Caregivers Can Use Cinesteam®'s Secondary Dressings to Improve Quality of Life in Palliative Care Settings. FOR...

Philips Delivers First-quarter Results in Line With 2024 Performance Improvement Plan; Resolves the Respironics Personal Injury and Medical Monitoring Litigation in the Us for USD 1.1 Billion

April 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4% Comparable order intake -3.8%, mainly due to China USD 1.1 b...